Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (19)

2023

  1. Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528] (Redox Biology (2020) 34, (S2213231720304882), (10.1016/j.redox.2020.101528))

    Redox Biology

  2. Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets

    Antioxidants and Redox Signaling, Vol. 39, Núm. 4-6, pp. 278-320

2022

  1. Impact of nitric oxide in liver cancer microenvironment

    Nitric Oxide - Biology and Chemistry, Vol. 128, pp. 1-11

  2. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734

  3. Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study

    Journal of Affective Disorders, Vol. 300, pp. 99-108

2021

  1. Methodologies for the determination of blood alpha1 antitrypsin levels: A systematic review

    Journal of Clinical Medicine, Vol. 10, Núm. 21

2020

  1. Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells

    Cell Death and Disease, Vol. 11, Núm. 5

  2. Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer

    Redox Biology, Vol. 34

  3. Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer

    Redox Biology, Vol. 36

  4. Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions

    Redox Biology, Vol. 34

  5. Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome

    Trends in Endocrinology and Metabolism, Vol. 31, Núm. 10, pp. 725-741

2018

  1. Alpha-1 antitrypsin deficiency: Outstanding questions and future directions

    Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1

  2. Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))

    Redox Biology

  3. Mitochondria, the NLRP3 inflammasome, and sirtuins in type 2 diabetes: New therapeutic targets

    Antioxidants and Redox Signaling, Vol. 29, Núm. 8, pp. 749-791

2017

  1. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

    Redox Biology, Vol. 13, pp. 94-162

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2010

  1. A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis

    Sarcoidosis Vasculitis and Diffuse Lung Diseases, Vol. 27, Núm. 2, pp. 121-130

2008

  1. Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression

    European Respiratory Journal, Vol. 32, Núm. 4, pp. 1004-1008